Crystallographic and Receptor Binding Characterization of Plasmodium falciparum Macrophage Migration Inhibitory Factor Complexed to Two Potent Inhibitors

We report the crystal structures of two inhibitors of Plasmodium falciparum macrophage migration inhibitory factor (PfMIF) with nanomolar Ki’s, analyze their interactions with the active site of PfMIF, and provide explanations regarding their selectivity of PfMIF versus human MIF. These inhibitors were also found to selectively inhibit interactions between PfMIF and the human MIF receptor CD74. The results of this study provide the framework for the development of new therapeutics that target PfMIF.

[1]  J. Bernhagen,et al.  Regulated secretion of macrophage migration inhibitory factor is mediated by a non‐classical pathway involving an ABC transporter , 2003, FEBS letters.

[2]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[3]  J. Bernhagen,et al.  The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer. , 1996, Protein engineering.

[4]  Atsushi Nakagawa,et al.  Crystal structure of the macrophage migration inhibitory factor from rat liver , 1996, Nature Structural Biology.

[5]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[6]  L. H. Chen,et al.  Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies. , 1996, Biochemistry.

[7]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[8]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[9]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[10]  T. Holowka,et al.  A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria , 2012, Proceedings of the National Academy of Sciences.

[11]  L. Leng,et al.  MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations , 2013, Proceedings of the National Academy of Sciences.

[12]  Julian Tirado-Rives,et al.  Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor. , 2012, Journal of medicinal chemistry.

[13]  R. Kuroki,et al.  The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Elias Lolis,et al.  Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor , 1998, The EMBO journal.

[15]  J. Bernhagen,et al.  Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Huiyong Sun,et al.  Current developments of macrophage migration inhibitory factor (MIF) inhibitors. , 2013, Drug discovery today.

[17]  Lin Leng,et al.  Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors. , 2011, Chemistry & biology.

[18]  J. Bernhagen,et al.  The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor1 , 2009, The Journal of Immunology.

[19]  S. Yamamoto,et al.  Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography. , 2001, Journal of medicinal chemistry.

[20]  A. Wilkinson,et al.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei , 2009, Protein science : a publication of the Protein Society.

[21]  A. Pain,et al.  Functional Characterization of the Plasmodium falciparum and P. berghei Homologues of Macrophage Migration Inhibitory Factor , 2006, Infection and Immunity.

[22]  Shoeb Ahmad,et al.  Probing protein stability and proteolytic resistance by loop scanning: A comprehensive mutational analysis , 2012, Protein science : a publication of the Protein Society.

[23]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[24]  M. Cascella,et al.  The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor. , 2008, Biochemistry.

[25]  H. Lashuel,et al.  An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. , 2010, Bioorganic & medicinal chemistry.

[26]  V. Pavlov,et al.  Alternative Chemical Modifications Reverse the Binding Orientation of a Pharmacophore Scaffold in the Active Site of Macrophage Migration Inhibitory Factor* , 2007, Journal of Biological Chemistry.

[27]  Z. Dauter,et al.  Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. , 1996, Biochemistry.

[28]  Youyong Li,et al.  Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays. , 2014, Journal of medicinal chemistry.

[29]  E. Morand,et al.  Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. , 2001, Arthritis and rheumatism.

[30]  M. Hodsdon,et al.  Structural interactions dictate the kinetics of macrophage migration inhibitory factor inhibition by different cancer-preventive isothiocyanates. , 2012, Biochemistry.

[31]  Piotr Sliz,et al.  Collaboration gets the most out of software , 2013, eLife.

[32]  Tina Peng,et al.  Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.

[33]  Sakae Tanaka,et al.  Macrophage Migration Inhibitory Factor Up-regulates Matrix Metalloproteinase-9 and -13 in Rat Osteoblasts , 2002, The Journal of Biological Chemistry.

[34]  W. L. Jorgensen,et al.  Benzisothiazolones as modulators of macrophage migration inhibitory factor. , 2011, Bioorganic & medicinal chemistry letters.

[35]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[36]  Zoe Cournia,et al.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. , 2009, Journal of medicinal chemistry.